Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T00:33:30.989Z Has data issue: false hasContentIssue false
  • English
  • Français

Tuberculin Skin Testing of Hospitalized Patients

Published online by Cambridge University Press:  02 January 2015

Keith F. Woeltje ,
Charles M. Kilo ,
Krista Johnson ,
Jonathon Primack  and
Victoria J. Fraser
Keith F. Woeltje
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Charles M. Kilo
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Krista Johnson
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Jonathon Primack
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Victoria J. Fraser*
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
*
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, Campus Box 8061, 660 South Euclid, St Louis, MO 63110
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

We sought to define the prevalence of tuberculin skin test (TST) positivity in a group of newly hospitalized patients, to identify risk factors for positive tests, and to examine the impact of testing on infection control practices.

Design:

Unblinded cohort study over 5 days in July 1992.

Setting:

A 1,000-bed university-affiliated hospital.

Patients:

All patients admitted (excluding obstetric patients and newborns) were interviewed. Patients without a history of tuberculosis (TB) or a positive TST were offered a TST with Candida and tetanus controls.

Results:

Of 346 patients offered the test, 21 (6%) had a prior history of TB or a positive TST, and 36 (10%) declined to participate; 279 of the remaining 289 completed the study. Anergy was demonstrated in 94 (33.7%) of 279 patients. New positive TSTs were identified in 19 (10.3%) of 185 nonanergic patients. Of the 19 TST-positive patients, 6 (32%) had infiltrates on chest radiographs and were evaluated for active TB. One patient was treated empirically for active TB, and five received isoniazid prophylaxis. Risk factors for a new positive TST included age (odds ratio [OR], 1.56 per decade of life; P=.021), African American race (OR, 4.81; P=.008), alcohol abuse (OR, 5.53; P=.005), and peptic ulcer disease (OR, 4.53; P=.017). Risk factors for anergy included admission to a surgical service (OR, 2.1; P=.006), current use of steroids (OR, 2.65; P=.005), and human immunodeficiency virus (HIV) infection (OR, undefined; P=.034).

Conclusions:

Despite a high rate of anergy, routine tuberculin skin testing identified a substantial number of patients with TB infection who might otherwise have gone unrecognized.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 8 , August 1997 , pp. 561 - 565
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control, Advisory Committee for the Elimination of Tuberculosis. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989;38(suppl 3):1–25.Google Scholar
2. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1623–1633.CrossRefGoogle Scholar
3. Brudney, K, Dobkin, J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745–749.CrossRefGoogle ScholarPubMed
4. Reichman, LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144:741–742. Editorial.Google Scholar
5. Dooley, SW, Villarino, ME, Lawrence, M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:2632–2634.CrossRefGoogle Scholar
6. Williams, J, Schneider, N, Gilligan, ME. Implementing a tuberculosis control program. Am J Infect Control 1995;23:152–155.Google Scholar
7. Jereb, JA, Klevens, RM, Privett, TD, et al. Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis . Arch Intern Med 1995;155:854–859.Google Scholar
8. Wenger, PN, Otten, J, Breeden, A, Orfas, D, Beck-Sague, CM, Jarvis, WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet 1995;345:235–240.CrossRefGoogle ScholarPubMed
9. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43:1–132.Google Scholar
10. Browder, AA, Griffon, AL. Tuberculin tine tests on medical wards. Am Rev Respir Dis 1972;105:299–301.Google Scholar
11. Taneja, R, Merritt, S, Vanek, S, Passannante, M, Livingston, DH. Tuberculin screening of trauma admissions at a university hospital. A preventive strategy. Arch Surg 1995;130:1223–1226; discussion 1226-1227.Google Scholar
12. Janis, EM, Allen, DW, Glesby, MM, et al. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Am J Med 1996;100:186–192.Google Scholar
13. Welty, C, Burstin, S, Muspratt, S, Tager, IB. Epidemiology of tuberculous infection in a chronic care population. Am Rev Respir Dis 1985;132:133–136.Google Scholar
14. Welke, H, Irsigler, GB, Kleeberg, HH. The diagnostic value of the tine and Mantoux tests in a general hospital. S Afr Med J 1976;50:2073–2076.Google Scholar
15. Simon, JA, McVicker, SJ, Ferrell, CR, Payne, CB Jr. Two-step tuberculin testing in a veterans domiciliary population. South Med J 1987;76:866–869.Google Scholar
16. Cobb, S, Hall, W. Newly identified cluster of diseases. Rheumatoid arthritis, peptic ulcer, and tuberculosis. JAMA 1965;193:1077–1079.Google Scholar
17. Palmer, DL, Reed, WP. Delayed hypersensitivity skin testing, I: response rates in a hospitalized population. J Infect Dis 1974;130:132–137.Google Scholar
18. Wright, PW, Crutcher, JE, Holiday, DB. Selection of skin test antigens to evaluate PPD anergy. J Fam Pract 1995;41:59–64.Google ScholarPubMed
19. Barry, MA, Regan, AM, Kunches, LM, Harris, ME, Bunce, SA, Craven, DE. Two-stage tuberculin testing with control antigens in patients residing in two chronic disease hospitals. J Am Geriatr Soc 1987;35:147–153.Google Scholar
20. Palmer, DL, Reed, WP. Delayed hypersensitivity skin testing, II: clinical correlates and anergy. J Infect Dis 1974;130:138–143.Google Scholar
21. McGowan, JE Jr. Hospital tuberculosis: beyond the inner city. Infect Control Hosp Epidemiol 1994;15:510–512.Google Scholar